repurposing
Drug repurposing allows a reconciliation of the time of research with the one of medicine in order to meet the high medical need
Drug screening
Screening of thousand molecules helps in identifying drug candidates for patients and potential new therapeutic targets.
development
The development of approved molecule is facilitated by the available knowledge produced by the former developments.
Apteeus has developed unique know-how and technology dedicated to drug discovery and repositioning. We are interested in pathologies for which the medical need is important and largely unsatisfied, particularly rare monogenic diseases. Our technology allows us to carry out discovery projects in a few months, and to identify new drug candidates. We work in collaboration with patient associations, doctors and academic and industrial partners.
OUR TECHNOLOGY
Operando®
OPERANDO is the biomedical research program in place for collecting cutaneous biopsies from patients in order to isolate the cells “model” of the pathology.
evidenceFactory®
evidenceFactory is the processes we use to measure, in vitro, the causal defects of the symptoms. Based on cell imaging and mass spectrometry, they are systematically miniaturized and automated to quickly test several thousand molecules.
TEE Library®
TEE Library is our proprietary collection of molecules approved for human use and enriched daily that we test in every new screen.
